Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Once-monthly octreotide acetate improves visual acuity in cystoid macular edema

May 12, 2003

Timolol 0.1% gel as effective as latanoprost 0.005% gel in early glaucoma

May 9, 2003

Santen files NDA for levofloxacin 1.5%

May 9, 2003

INS-37217 reported effective as adjunct in retinal reattachment surgery

May 9, 2003

Improved retinal thickness found with midostaurin in diabetic macular edema

May 8, 2003

Dry eye symptoms improve after transdermal application of testosterone cream

May 8, 2003

Cell adhesion inhibitor K-7174 exerts beneficial effects in murine model of Sjogren's syndrome

May 7, 2003

Roscovitine inhibits the proliferation of RPE cells

May 7, 2003

Porphyrin-based photosensitizers for use in ocular disorders, cancer, etc.

May 7, 2003

Approval and/or launch of major ophthalmic products reported by Allergan

May 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...